Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis

  1. Richardson, P.G.
  2. Perrot, A.
  3. Miguel, J.S.
  4. Beksac, M.
  5. Spicka, I.
  6. Leleu, X.
  7. Schjesvold, F.
  8. Moreau, P.
  9. Dimopoulos, M.A.
  10. Huang, S.-Y.
  11. Minarik, J.
  12. Cavo, M.
  13. Prince, H.M.
  14. Macé, S.
  15. Zhang, R.
  16. Dubin, F.
  17. Morisse, M.C.
  18. Anderson, K.C.
Aldizkaria:
Haematologica

ISSN: 1592-8721,  0390-6078

Argitalpen urtea: 2024

Alea: 109

Zenbakia: 7

Orrialdeak: 2239-2249

Mota: Artikulua

DOI: 10.3324/HAEMATOL.2023.284325 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus